Beyond its pro-tumorigenic roles, IL-6 promotes angiogenesis by the VEGF signal pathway, thereby weakening the effectiveness of ICIs in many types of cancers, including gastrointestinal cancers, prostate cancer, oral squamous cell carcinoma, and hepatocellular carcinoma (38–40). The gene discussed is IL6; the disease is oral cavity squamous cell carcinoma.